JOURNAL OF PSYCHOACTIVE DRUGS

Scope & Guideline

Pioneering Research in Psychoactive Substance Dynamics

Introduction

Delve into the academic richness of JOURNAL OF PSYCHOACTIVE DRUGS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0279-1072
PublisherROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1967 to 1972, from 1974 to 2024
AbbreviationJ PSYCHOACTIVE DRUGS / J. Psychoact. Drugs
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND

Aims and Scopes

The 'Journal of Psychoactive Drugs' focuses on a multidisciplinary approach to the study of psychoactive substances and their effects, encompassing various aspects of drug use, including health, psychology, sociology, and policy. The journal aims to advance the understanding of psychoactive drugs through empirical research, theoretical frameworks, and reviews that highlight the complexities surrounding substance use and its societal implications.
  1. Psychedelic Research and Therapeutics:
    The journal emphasizes the therapeutic potential of psychedelics, exploring their use in treating mental health disorders, substance use disorders, and other psychological conditions.
  2. Substance Use Epidemiology:
    Research focusing on the prevalence, patterns, and correlates of psychoactive substance use across different populations, including marginalized and vulnerable groups.
  3. Cultural and Social Contexts of Drug Use:
    Investigates the cultural, social, and community aspects of drug use, including stigma, identity, and the impact of drug policies on different populations.
  4. Harm Reduction Strategies:
    Promotes research on harm reduction approaches, assessing their effectiveness and implementation in various settings, particularly for high-risk substance users.
  5. Psychosocial Factors and Substance Use:
    Examines the psychological, social, and behavioral factors that influence substance use, including coping strategies, mental health comorbidities, and recovery processes.
The 'Journal of Psychoactive Drugs' has seen a significant evolution in its research themes, with certain topics gaining increased attention in recent publications. This section identifies emerging themes that are shaping the journal's current focus, reflecting contemporary issues and innovative research directions.
  1. Psychedelic-Assisted Therapies:
    There is a growing body of research investigating the applications of psychedelics in therapeutic settings, especially concerning mental health disorders such as depression, PTSD, and anxiety.
  2. Impact of Legalization and Policy Change:
    Emerging studies focus on the implications of drug legalization and policy changes, particularly surrounding cannabis and the societal impacts of these shifts.
  3. Intersection of Substance Use and Mental Health:
    Research increasingly explores the interplay between substance use and mental health, highlighting comorbidities and integrated treatment approaches.
  4. Community-Based Drug Interventions:
    There is an increasing emphasis on community-level interventions and harm reduction strategies that consider local cultural contexts and community health.
  5. Microdosing Practices and Effects:
    The phenomenon of psychedelic microdosing is gaining traction, with studies examining its effects on creativity, mental health, and overall well-being.

Declining or Waning

While the journal continues to publish a broad range of topics, certain themes appear to be declining in prominence over recent years. This section highlights the areas that have seen reduced focus or interest among researchers, indicating potential shifts in the field's priorities or emerging trends overshadowing these topics.
  1. Traditional Drug Use Studies:
    There is a noticeable decrease in studies focused solely on traditional or historical uses of substances without a contemporary context, reflecting a shift towards more applied and intervention-focused research.
  2. Basic Pharmacological Studies:
    Research centered on basic pharmacology of psychoactive substances, such as isolated pharmacodynamics or pharmacokinetics, has waned in favor of studies that address clinical implications and real-world applications.
  3. General Attitudes Towards Drug Use:
    Papers exploring general public attitudes towards drug use, without a specific focus on therapeutic or harm reduction implications, seem to be less frequently published.
  4. Non-Psychoactive Substances:
    Research on substances that are not considered psychoactive (e.g., certain dietary supplements or non-drug interventions) has become less common, as the journal's focus has shifted more towards psychoactive drugs.

Similar Journals

Harm Reduction Journal

Elevating the discourse on harm reduction and mental health.
Publisher: BMCISSN: Frequency: 1 issue/year

Welcome to the Harm Reduction Journal, a premier academic platform published by BMC, dedicated to advancing the field of harm reduction since its inception in 2004. With an impressive track record as an Open Access publication, this journal addresses critical topics within the broad scope of medicine, psychiatry, and public health, making it indispensable for researchers, healthcare professionals, and students alike. As of 2023, it proudly holds a Q1 ranking in prestigious categories including Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, reflecting its high impact and significance in the academic community. The journal is notable for its comprehensive discussions on innovative harm reduction strategies, public policy considerations, and evidence-based practice, fostering collaboration and knowledge exchange. With a global reach and commitment to enhancing health outcomes, the Harm Reduction Journal serves as a vital resource in the ever-evolving landscape of public health and addiction research.

Drugs Habits and Social Policy

Advancing Insights for Health Policy Transformation
Publisher: EMERALD GROUP PUBLISHING LTDISSN: 2752-6739Frequency: 4 issues/year

Drugs Habits and Social Policy is an esteemed academic journal published by Emerald Group Publishing Ltd that focuses on the intersection of drug habits and the evolving landscape of social policy. With an ISSN of 2752-6739 and E-ISSN of 2752-6747, this journal contributes significantly to the fields of Clinical Psychology, Health Policy, and Public Health, and is ranked in the Q3 category across multiple disciplines in the 2023 categorizations. Featuring research that spans from 2022 to 2024, the journal provides a platform for critical insights and evidence-based discussions that are essential for understanding the social implications of drug use. Despite its current quartile ranking, the journal aims to elevate discourse among researchers, professionals, and students alike, reinforcing its commitment to impactful scholarship that can inform policy and practice. The journal is based in the United Kingdom, with its operations housed at Floor 5, Northspring 21-23 Wellington Street, Leeds, W YORKSHIRE LS1 4DL, ENGLAND. As a pivotal resource in its field, Drugs Habits and Social Policy invites contributions that can shape the future of health policy and improve societal outcomes.

Journal of Addictions Nursing

Leading the Charge in Addiction Treatment Knowledge
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1088-4602Frequency: 4 issues/year

The Journal of Addictions Nursing, published by Lippincott Williams & Wilkins, serves as a pivotal resource in the field of psychiatric and mental health nursing. With an ISSN of 1088-4602 and an E-ISSN of 1548-7148, this esteemed journal has been dedicated to advancing the knowledge and practice of addiction nursing since its inception in 1989. As of 2023, it ranks in the Q3 category of psychiatry and mental health, highlighting its significance amidst its peers. The journal provides a platform for the dissemination of original research, reviews, and clinical practices that address the complexities of addiction treatment and care. While it currently does not offer open access options, its valuable insights are accessible to practitioners and researchers committed to improving patient outcomes. With content spanning from 1989 to 2024, the journal continues to shape the discourse in this vital area of nursing, making it an essential read for professionals and scholars aiming to stay at the forefront of addiction nursing and intervention strategies.

Journal of Mental Health and Human Behaviour

Exploring the intersection of mental health and human behaviour.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0971-8990Frequency: 2 issues/year

The Journal of Mental Health and Human Behaviour is a distinguished publication dedicated to advancing the field of mental health, focusing on innovative research and practical applications that enhance human behaviour and overall well-being. Published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, this journal has been an open-access platform since 2014, enabling wider dissemination of knowledge and fostering collaboration among researchers, professionals, and students globally. With an ISSN of 0971-8990 and E-ISSN 2543-1897, it aims to provide a comprehensive array of peer-reviewed articles that cover various facets of mental health, including psychological theories, therapeutic practices, and sociocultural influences. The journal plays an integral role in bridging the gap between research and practice, making it essential for those who are committed to improving mental health outcomes and advocating for human behaviour change. Published in India, the journal not only highlights regional issues but also contributes to international discussions on mental health trends and interventions, affirming its importance in a rapidly evolving field.

ADDICTIVE BEHAVIORS

Bridging Research and Practice in Addiction Studies
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0306-4603Frequency: 12 issues/year

ADDICTIVE BEHAVIORS is a prestigious journal published by PERGAMON-ELSEVIER SCIENCE LTD, specializing in the critical examination and exploration of addiction-related issues across diverse fields including Clinical Psychology, Psychiatry and Mental Health, and Toxicology. With a robust history dating back to 1975 and convergence extending to 2024, the journal is esteemed for its rigorous peer-reviewed research that contributes significantly to understanding addiction phenomena. Ranked in the Q1 category for its focus areas, it stands out within the academic community, evidenced by its impressive Scopus rankings—25th in Clinical Psychology and 14th in Toxicology—placing it in the top tier of its disciplines. This journal offers valuable insights into addiction behaviors, treatment methodologies, and public health implications, making it an essential resource for researchers, practitioners, and students seeking to advance their knowledge and impact the field. Although not Open Access, it provides vital access options for institutions and individuals invested in addiction studies.

DRUGS-EDUCATION PREVENTION AND POLICY

Cultivating informed discussions on drug prevention and policy.
Publisher: TAYLOR & FRANCIS LTDISSN: 0968-7637Frequency: 6 issues/year

DRUGS-EDUCATION PREVENTION AND POLICY is a premier scholarly journal published by Taylor & Francis Ltd, focusing on the critical intersection of drug education, prevention strategies, and policy formulation. Established in 1994 and continuing through its converged years into 2024, this journal holds significant relevance within the health and social sciences fields, with commendable standings reflected in its 2023 category quartile rankings of Q2 in both Health (Social Science) and Medicine (Miscellaneous). With an impact ranking that places it in the 73rd and 67th percentiles respectively, it serves as an influential platform for researchers, professionals, and students to disseminate innovative research, case studies, and policy analyses. Those interested in the complexities of drug-related issues are encouraged to explore the insights provided by this journal, contributing to the ongoing discourse in effective prevention and education practices in the context of drug use and its social implications. Although access to articles is not open, the wealth of knowledge presented is invaluable for academia and policy formulation alike.

SUBSTANCE USE & MISUSE

Empowering professionals with evidence-based insights on substance misuse.
Publisher: TAYLOR & FRANCIS INCISSN: 1082-6084Frequency: 14 issues/year

SUBSTANCE USE & MISUSE, published by Taylor & Francis Inc, is an esteemed academic journal dedicated to the multifaceted study of substance use and its implications on health and society. With a notable impact factor and categorized in the Q2 quartile across multiple fields—including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, as well as Public Health—this journal serves as an essential platform for researchers, professionals, and students alike. Spanning from 1966 to 2024, it provides a rich archive of peer-reviewed articles that explore current trends, innovative research, and evidence-based practices in the management and understanding of substance use. The journal offers various access options, catering to the diverse needs of its audience and affirming its commitment to fostering scholarly discourse in the United Kingdom and beyond. By engaging with this journal, readers can enhance their understanding of the complexities surrounding substance use, making it a crucial resource for advancing knowledge and informing policy in this critical area of public health.

Substance Abuse

Exploring innovative interventions for lasting recovery.
Publisher: SAGE PUBLICATIONS INCISSN: 0889-7077Frequency: 4 issues/year

Substance Abuse is a premier scholarly journal published by SAGE Publications Inc, dedicated to advancing the understanding and treatment of substance use disorders. With an established presence from 1995 to 2023, the journal boasts an impressive Q1 ranking in both Medicine (miscellaneous) and Psychiatry and Mental Health, positioning it among the top tier of academic publications in these fields. Researchers and professionals will find its articles, which are grounded in rigorous empirical studies and innovative interventions, essential for addressing the complex and multifaceted nature of substance abuse. Although not an open access publication, Substance Abuse maintains a commitment to sharing valuable insights and findings, making it a vital resource for those looking to enhance their knowledge and practice. Located in Thousand Oaks, CA, this journal serves as a critical forum for international dialogue and research dissemination, ensuring that current trends and challenges in substance use are thoughtfully examined and discussed within the academic community.

DRUG AND ALCOHOL DEPENDENCE

Connecting research and practice in substance use disorders.
Publisher: ELSEVIER IRELAND LTDISSN: 0376-8716Frequency: 12 issues/year

Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.

Journal of Substance Use & Addiction Treatment

Elevating standards in addiction treatment research.
Publisher: ELSEVIER SCIENCE INCISSN: 2949-8767Frequency: 12 issues/year

Journal of Substance Use & Addiction Treatment is a premier scholarly publication dedicated to advancing the understanding and treatment of substance use disorders and addictive behaviors. Published by Elsevier Science Inc, this journal serves as a vital platform for researchers, clinicians, and students in the fields of psychology, psychiatry, public health, and addiction studies. With its commitment to Open Access, the journal facilitates wide dissemination of cutting-edge research, enabling practitioners and policymakers to access critical findings that inform treatment approaches and public health strategies. As an essential resource in addiction treatment and research, the Journal of Substance Use & Addiction Treatment aims to foster interdisciplinary collaboration and innovation, ultimately improving outcomes for individuals affected by addiction.